scispace - formally typeset
J

John J. Collins

Researcher at Yale University

Publications -  299
Citations -  10018

John J. Collins is an academic researcher from Yale University. The author has contributed to research in topics: Judaism & Dead Sea Scrolls. The author has an hindex of 50, co-authored 296 publications receiving 9702 citations. Previous affiliations of John J. Collins include DePaul University & University of Massachusetts Medical School.

Papers
More filters
Journal ArticleDOI

Predictors of Atrial Fibrillation After Coronary Artery Surgery Current Trends and Impact on Hospital Resources

TL;DR: In this paper, a prospective study was conducted to determine the current incidence of atrial fibrillation after coronary artery bypass surgery (CABG), identify its clinical predictors, and examine its impact on resource utilization.
Journal ArticleDOI

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

Viviana Galimberti, +201 more
- 01 Oct 2018 - 
TL;DR: The findings of the IBCSG 23-01 trial corroborate those obtained at 5 years and are consistent with those of the 10-year follow-up analysis of the Z0011 trial, and support the current practice of not doing an axillary dissection when the tumour burden in the sentinel nodes is minimal or moderate.
Journal ArticleDOI

End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation

TL;DR: End-systolic volume is an easily determinable parameter of left ventricular function which appears to provide a measure for the onset of myocardial dysfunction in patients with these lesions and has major prognostic importance.
Journal ArticleDOI

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

TL;DR: CMF tolerability and effectiveness were both reduced for older patients compared with younger postmenopausal node-positive breast cancer patients who received tamoxifen for 5 years, suggesting the development and evaluation of less toxic and more effective chemotherapy regimens are required for high-risk elderly patients.
Journal ArticleDOI

Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease.

TL;DR: The immediate and short-term prognostic values of increased left ventricular end-diastolic pressure, reduced cardiac index and depressed ejection fraction determined during preoperative evaluation were compared in 128 patients undergoing coronary revascularization and 44 patients undergoing cardiac valve replacement.